Literature DB >> 12410357

Carotid endarterectomy contralateral to carotid artery occlusion: analysis from a randomized study.

Enzo Ballotta1, Giuseppe Da Giau, Claudio Baracchini.   

Abstract

BACKGROUND AND AIMS: Many studies have reported the benefits of carotid endarterectomy (CEA) contralateral to an occluded internal carotid artery (ICA), with varying results. This study analyzed perioperative and late outcomes in a recent trial in which patients were randomized to carotid eversion endarterectomy (CEE) or traditional CEA with patching (CEAP). PATIENTS AND METHODS: In 336 primary CEAs (310 patients) 68 were contralateral to an occluded ICA (group I). The remaining 268 CEAs served as control group (group II). All patients underwent clinical follow-up and duplex ultrasonography at 1, 6, and 12 months and every year thereafter. Endpoints of the study were early and late neurological events, and deaths.
RESULTS: Group I had a significantly higher incidence of perioperative electroencephalic changes and need for shunting. The perioperative stroke rate in group I was almost three times as high as in group II, but the difference was not significant. Similarly, the perioperative minor neurological event and death rates, as with the cumulative stroke-free and survival rates at 1, 3, and 5 years, were comparable in the two groups.
CONCLUSIONS: CEA contralateral to an occluded ICA can be implemented with perioperative stroke and mortality rates and late stroke-free and survival rates comparable to CEA with no contralateral ICA occlusion.

Entities:  

Mesh:

Year:  2002        PMID: 12410357     DOI: 10.1007/s00423-002-0312-z

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  1 in total

1.  Impact of practice patterns in shunt use during carotid endarterectomy with contralateral carotid occlusion.

Authors:  Philip P Goodney; Jessica B Wallaert; Salvatore T Scali; David H Stone; Virendra Patel; Palma Shaw; Brian W Nolan; Jack L Cronenwett
Journal:  J Vasc Surg       Date:  2011-11-03       Impact factor: 4.268

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.